Real world survey of Edoxaban for non-valvular atrial fibrillation patients using a Japanese healthcare database. - Real world survey of Edoxaban for non-valvular atrial fibrillation patients using a Japanese healthcare database.

Total of 4,144 edoxaban-treated patients were matched with same number of warfarin patients and no-anticoagulant patients. Median follow-up period for the edoxaban arm, warfarin arm, and no-anticoagulant arm was 82, 39, and 324 days. For the comparison of the edoxaban and warfarin arms, and edoxaban and no-anticoagulant arm, no difference was found in the incidence of stroke/systemic embolism. The findings are limited by the short mean follow-up period in both treatment arms.